Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis MARKET DYNAMICS Stringent cost and payer controls OPPORTUNITIES Impact Level Increasing studies on oral GLP-1 Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis Rapid expansion of manufacturing capacity is driving growth across the pharmaceutical market, especially for high-demand drugs like GLP-1 analogs
Featured Experts Amanda Kahn, MD is a board-certified internist in New York Sara Velayati, MD is a board-certified internist at Montefiore Einstein in New York Valerie D
Join the 10 million people who have already experienced the future of healthcare
doi: 10.1208/s12248-015-9719-7
For example, if you carry variants associated with slower GLP-1 receptor signaling, your provider might anticipate a more gradual dose escalation, potentially reducing nausea and improving long-term adherence to treatment